abstract |
The invention relates to a pharmaceutical composition for treating or preventing a malignant tumor which comprises, as a therapeutic agent, a polypeptide recognized by the antibody produced by the hybridoma ATCC ndegree HB 8630, or alternatively, a virus. into the genome of which is inserted a DNA bundle encoding the polypeptide mentioned above. |